Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia
Year: 2004
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Leukemia
Authors: R F Schlenk, S Fröhling, F Hartmann, J Th Fischer, A Glasmacher, F del Valle, W Grimminger, K Götze, C Waterhouse, R Schoch, H Pralle, H G Mergenthaler, M Hensel, E Koller, H Kirchen, J Preiss, H Salwender, H G Biedermann, S Kremers, F Griesinger, A Benner, B Addamo, K Döhner, R Haas, H Döhner, for the AML Study Group Ulm
Institutions: Universität Ulm, Städtisches Klinikum Karlsruhe, University of Bonn, Klinikum Oldenburg, Klinikum Stuttgart, Technical University of Munich, München Klinik Schwabing, München Klinik, Christian-Albrechts-Universität zu Kiel, Justus-Liebig-Universität Gießen, Heidelberg University, Hanusch Hospital, Krankenhaus der Barmherzigen Brüder Trier, cts CaritasKlinikum Saarbrücken, Asklepios Klinik Altona, Kreisklinik Trostberg, University of Göttingen, German Cancer Research Center, Heinrich Heine University Düsseldorf
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2065285477
